Health Care Supplies

According to Piper Jaffray, Merit Medical Systems (NASDAQ: MMSI) price target is lowered to $18. Piper Jaffray said that it is lowering its price target due to a decrease in the market multiple. “We maintain our Overweight rating on Merit Medical while lowering our price target to $18 (from $21...

Piper Jaffray has lowered the price target on Merit Medical Systems (NASDAQ: MMSI) from $21 to $18 and maintains its Overweight rating.

Shares of The Cooper Companies (NYSE: COO) are trading higher in the after-hours following the release of the company's Q3 earnings results. Currently, shares are higher by 2.76%, trading at $77.35; they ended the regular session lower by 0.09%, at $75.27. The Cooper Companies reported Q3 non-...

Joy Global Inc (NASDAQ: JOYG) is projected to report its FQ3 EPS at $1.53 on revenue of $1.17 billion. Shuffle Master Inc (NASDAQ: SHFL) is expected to report its Q3 EPS at $0.15 on revenue of $58.14 million. The Fresh Market Inc (NASDAQ: TFM) is estimated to report its Q2 EPS at $0.19 on revenue...

Last week we only had 2 stocks on our 8/19 "Stocks to Watch This Week" list.  The list is based on stocks reaching 52 week highs on two times relative volume on Friday.  When the US equity market struggles as it has in recent weeks, this is reflected in the number of stocks qualifying for the list...

Susser Holdings Corporation (NASDAQ: SUSS) shares rose 2.73% to create a new 52-week high of $19.93. SUSS shares have surged 69.14% over the past 52 weeks, while the S&P 500 index has gained 4.84% in the same period. STAAR Surgical Company (NASDAQ: STAA) shares gained 2.16% to create a new 52-...

Neogen Corporation (Nasdaq: NEOG) has announced that its GeneSeek subsidiary is a participant in USDA-funded research that seeks to better understand the role cattle genetics may play in food contamination by the pathogen E. coli O157:H7. GeneSeek is considered the leading commercial agricultural...

According to Morgan Keegan, Cooper Companies (NYSE: COO) announced voluntary recall of Avaira Toric contact lenses. Morgan Keegan said that Cooper announced a voluntary recall on limited lots of Avaira Toric contact lenses following a small number of reports regarding temporary hazy vision. “...

The US Equity market had another volatile week and stocks have struggled to attain new highs.  Investors with exposure to gold and bonds have done well this month and I've reiterated a relative momentum ETF strategy that has capitalized on this trend by investing in GLD, IEF, TIP, and PCY. Now you...

The Cooper Companies, Inc. (NYSE: COO) today announced that its subsidiary CooperVision has initiated a voluntary recall on limited lots of Avaira® Toric contact lenses. This recall is limited solely to specific lots of Avaira Toric, and no other CooperVision product is involved in this recall....

DENTSPLY International Inc. (Nasdaq: XRAY) today announced that it has received regulatory approval from the relevant national competition authorities to proceed with the acquisition of the shares of Astra Tech AB, a leading provider of dental implant and urology products, based in Mölndal, Sweden...

Immucor, Inc. (Nasdaq: BLUD) and TPG Capital, L.P. today announced the successful acquisition of the Company by IVD Acquisition Corporation, an affiliate of TPG Capital, for $27.00 per share in cash, or approximately $1.939 billion in the aggregate. Today, following the consummation of the tender...

Cook Incorporated, a global leader in endovascular technologies, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana in Indianapolis has issued a Markman ruling in the ongoing patent infringement lawsuit filed against Endologix (...

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced the appointment of Jing-wen Kuo, Ph.D. as chief scientific officer. For the last nine years, Dr. Kuo has served in a variety of consulting capacities to many US and international clients specializing in hyaluronic acid based medical products...

Cerus Corporation (NASDAQ: CERS) announced today that it has received a $2.1 million award from the U.S. Department of Defense to support the advanced development of the company's technology for inactivating pathogens and leukocytes in red blood cells. Cerus is developing the INTERCEPT system for...